1.38
price down icon3.50%   -0.05
after-market Handel nachbörslich: 1.38
loading
Schlusskurs vom Vortag:
$1.43
Offen:
$1.41
24-Stunden-Volumen:
304.46K
Relative Volume:
1.67
Marktkapitalisierung:
$43.05M
Einnahmen:
$81,000
Nettoeinkommen (Verlust:
$-41.04M
KGV:
-1.0479
EPS:
-1.3169
Netto-Cashflow:
$-30.69M
1W Leistung:
-9.80%
1M Leistung:
-12.66%
6M Leistung:
-10.97%
1J Leistung:
-19.30%
1-Tages-Spanne:
Value
$1.36
$1.43
1-Wochen-Bereich:
Value
$1.36
$1.5535
52-Wochen-Spanne:
Value
$1.06
$2.41

Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile

Name
Firmenname
Actinium Pharmaceuticals Inc
Name
Telefon
646-767-3870
Name
Adresse
275 Madison Avenue, 7th Floor, New York, NY
Name
Mitarbeiter
25
Name
Twitter
@actiniumpharma
Name
Nächster Verdiensttermin
2025-08-08
Name
Neueste SEC-Einreichungen
Name
ATNM's Discussions on Twitter

Vergleichen Sie ATNM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ATNM
Actinium Pharmaceuticals Inc
1.38 44.61M 81,000 -41.04M -30.69M -1.3169
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-08-07 Herabstufung B. Riley Securities Buy → Neutral
2024-05-14 Eingeleitet Stephens Overweight
2023-09-06 Eingeleitet HSBC Securities Buy
2023-02-21 Herabstufung William Blair Outperform → Mkt Perform
2022-09-08 Eingeleitet Cantor Fitzgerald Overweight
2022-08-25 Eingeleitet B. Riley Securities Buy
2020-11-05 Eingeleitet Alliance Global Partners Buy
2017-12-06 Eingeleitet B. Riley FBR, Inc. Buy
2017-10-23 Fortgesetzt ROTH Capital Buy
2017-09-14 Eingeleitet Maxim Group Buy
2016-08-25 Eingeleitet ROTH Capital Buy
2016-02-29 Eingeleitet H.C. Wainwright Buy
2015-10-15 Eingeleitet FBR Capital Outperform
2014-10-01 Eingeleitet MLV & Co Buy
2014-07-22 Eingeleitet Canaccord Genuity Buy
Alle ansehen

Actinium Pharmaceuticals Inc Aktie (ATNM) Neueste Nachrichten

pulisher
09:42 AM

How moving averages guide Actinium Pharmaceuticals Inc. tradingWeekly Profit Summary & Weekly High Potential Stock Alerts - newser.com

09:42 AM
pulisher
09:29 AM

Identifying reversal signals in Actinium Pharmaceuticals Inc.Weekly Stock Analysis & Capital Efficiency Focused Ideas - newser.com

09:29 AM
pulisher
09:20 AM

What momentum shifts mean for Actinium Pharmaceuticals Inc.July 2025 Opening Moves & Community Consensus Stock Picks - newser.com

09:20 AM
pulisher
08:57 AM

Why retail traders accumulate Actinium Pharmaceuticals Inc. (Delaware) stockDividend Hike & Safe Capital Growth Tips - newser.com

08:57 AM
pulisher
08:50 AM

Is Actinium Pharmaceuticals Inc. stock ready for a breakoutJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com

08:50 AM
pulisher
08:30 AM

Actinium Pharmaceuticals, Inc. to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference - PR Newswire

08:30 AM
pulisher
05:40 AM

Is Actinium Pharmaceuticals Inc. (7AY1) stock a momentum leaderWeekly Volume Report & Short-Term High Return Strategies - newser.com

05:40 AM
pulisher
04:23 AM

Can you recover from losses in Actinium Pharmaceuticals Inc.July 2025 Opening Moves & AI Optimized Trade Strategies - newser.com

04:23 AM
pulisher
04:06 AM

How Actinium Pharmaceuticals Inc. stock performs in rate cut cycles2025 Trade Ideas & Accurate Buy Signal Notifications - newser.com

04:06 AM
pulisher
04:00 AM

How Actinium Pharmaceuticals Inc. (Delaware) stock expands through international markets2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - newser.com

04:00 AM
pulisher
03:44 AM

Is Actinium Pharmaceuticals Inc. stock entering bullish territoryJuly 2025 Closing Moves & Stepwise Trade Execution Plans - newser.com

03:44 AM
pulisher
01:46 AM

How supply shortages influence Actinium Pharmaceuticals Inc. (Delaware) stockTrade Exit Summary & Low Risk High Win Rate Picks - newser.com

01:46 AM
pulisher
Nov 02, 2025

How Actinium Pharmaceuticals Inc. (Delaware) stock stacks up against competitors2025 Year in Review & Low Risk High Reward Trade Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Actinium Pharmaceuticals Inc. stock a smart buy before Fed meeting2025 Top Gainers & Verified Momentum Stock Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will Actinium Pharmaceuticals Inc. (7AY1) stock outperform foreign stocksEntry Point & Weekly Breakout Opportunity Watchlist - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Why Actinium Pharmaceuticals Inc. (Delaware) stock stays undervaluedMarket Volume Summary & AI Based Buy and Sell Signals - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

How Actinium Pharmaceuticals Inc. (Delaware) stock responds to bond marketJuly 2025 Volume & Fast Moving Market Watchlists - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Will Actinium Pharmaceuticals Inc. (7AY1) stock gain from lower interest ratesQuarterly Market Summary & Community Consensus Trade Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 04:06:04 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Actinium Pharmaceuticals Inc. (Delaware) stock a buy on weaknessWeekly Risk Report & AI Powered Buy and Sell Recommendations - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Actinium Pharmaceuticals, Inc. (ATNM) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 30, 2025
pulisher
Oct 30, 2025

Published on: 2025-10-30 03:05:03 - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Published on: 2025-10-29 21:28:17 - newser.com

Oct 29, 2025

Finanzdaten der Actinium Pharmaceuticals Inc-Aktie (ATNM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):